- Home
- AAPG
as 03-28-2025 4:00pm EST
Ascentage Pharma Group International is a clinical-stage biotechnology company engaged in the development and sales of novel small-scale therapies for cancers, hepatitis B virus, or HBV, and certain age-related diseases. It focuses on developing therapies that inhibit protein-protein interactions to restore apoptosis or programmed cell death. The company's geographical segments include the United States and Mainland China.
| Founded: | 2009 | Country: | China |
| Employees: | N/A | City: | N/A |
| Market Cap: | 1.7B | IPO Year: | 2025 |
| Target Price: | N/A | AVG Volume (30 days): | 24.9K |
| Analyst Decision: | Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -0.18 | EPS Growth: | N/A |
| 52 Week Low/High: | $16.50 - $22.43 | Next Earning Date: | 03-27-2025 |
| Revenue: | $134,352,180 | Revenue Growth: | 341.77% |
| Revenue Growth (this year): | 328.14% | Revenue Growth (next year): | -43.23% |
Latest Ascentage Pharma Group International American Depository Shares News
AAPG Breaking Stock News: Dive into AAPG Ticker-Specific Updates for Smart Investing
Simply Wall St.
4 days ago
Asian Growth Stocks With Strong Insider Confidence
Simply Wall St.
4 days ago
Exploring XD And Two Other High Growth Tech Stocks In Asia
MT Newswires
4 days ago
Sector Update: Health Care Stocks Flat to Higher Premarket Thursday
MT Newswires
4 days ago
Ascentage Pharma Group's 2024 Loss Narrows, Revenue Rises
GlobeNewswire
4 days ago
Ascentage Pharma Reports Full Year 2024 Unaudited Financial Results and Business Updates
GlobeNewswire
6 days ago
Ascentage Pharma to Present Five Preclinical Studies from Innovative Pipeline at American Association of Cancer Research (AACR) Annual Meeting 2025
GlobeNewswire
19 days ago
Ascentage Pharma to Report Full Year 2024 Financial Results and Provide Corporate Update on March 27, 2025
Exec Edge
25 days ago
Ascentage Secures Third Breakthrough Therapy for Ph+ ALL Treatment
Compare AAPG vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "AAPG Ascentage Pharma Group International American Depository Shares - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.